Conference item : Abstract
89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Bibliographic Details
- Publisher:
- Society of Nuclear Medicine Publisher's website
- Journal:
- Journal of Nuclear Medicine Journal website
- Volume:
- 57
- Issue:
- S2
- Article number:
- 333
- Host title:
- Journal of Nuclear Medicine
- Publication date:
- 2016-05-01
- EISSN:
-
2159-662X
- ISSN:
-
0161-5505
- Source identifiers:
-
917722
Item Description
- Subtype:
- Abstract
- Pubs id:
-
pubs:917722
- UUID:
-
uuid:84b0b253-661b-48b6-926b-3910c8d715fc
- Local pid:
- pubs:917722
- Deposit date:
- 2018-10-30
Terms of use
- Copyright holder:
- Knight et al
- Copyright date:
- 2016
- Notes:
- Presented at the SNMMI Annual Meeting 2016. This abstract is available at http://jnm.snmjournals.org/content/57/supplement_2/333.abstract
If you are the owner of this record, you can report an update to it here: Report update to this record